Free delivery over $100 Learn more

30 days return period Learn more

SKU: 0308ATC

PL-21 Human Peripheral Blood Specialized Cells


Tumor Cell Lines > Leukemia Cell Lines

Product Type: Human Leukemia Cell Lines

Species: Human

Cell Type: Other / Specialized Cells

Source Organ: Blood


Regular price $1,249.00

Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: PL-21

PL-21 Cell Line is from human; Sex: M; Tissue: hemo-lymphocytic; Morphology: myeloid; Profile: Human myeloid cell line derived from an acute promyelocytic leukemia.

  • Description
    PL-21 is a human acute promyelocytic leukemia (APL) cell line, classified under FAB M3 subtype, it was derived from the peripheral blood of a 24-year-old male patient. Unlike typical APL lines, PL-21 lacks the classic APL-associated t(15;17) translocation, making it a distinctive model for studying non-canonical APL pathways. PL-21 cells grow in single-cell suspension, display features of immature nuclei and prominent cytoplasmic azurophilic granules. They exhibit monocytic differentiation profile, confirmed by the strong expression of surface markers CD14/CD68 and the presence of monocyte-specific esterase. PL-21 lacks lymphoid characteristics and is EBNA-negative. Its capacity makes it particularly valuable for investigating non-canonical APL pathways.
  • Product Name
    PL-21
  • Product Type
    Human Leukemia Cell Lines
  • Species
    Human
  • Source Organ
    Peripheral Blood
  • Product Type
    Human Leukemia Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    PL-21 cell line serves as a unique and versatile model in leukemia research, particularly for exploring non-classical APL mechanisms. It provides excellent platform for studying myeloid cell proliferation and differentiation mechanisms. Additionally, researchers have employed PL-21 cells to investigate the roles of key oncogenic drivers such as p53, FLT3, and KRAS, offering critical insights into their involvement in leukemogenesis and therapeutic resistance. Due to its distinct genetic and phenotypic profile, PL-21 is highly suitable for drug screening, molecular pathway analysis, and the development of targeted treatments for atypical forms of AML and APL.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 20% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.